| 000 | 01822 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515080837.0 | ||
| 264 | 0 | _c20070925 | |
| 008 | 200709s 0 0 eng d | ||
| 022 | _a1521-0669 | ||
| 024 | 7 |
_a10.1080/08880010701451434 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKoksal, Yavuz | |
| 245 | 0 | 0 |
_aDysgerminoma in a child with ataxia-telangiectasia. _h[electronic resource] |
| 260 |
_bPediatric hematology and oncology _cSep 2007 |
||
| 300 |
_a431-6 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aAtaxia Telangiectasia _xblood |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aBleomycin _xadministration & dosage |
| 650 | 0 | 4 |
_aCA-125 Antigen _xblood |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aChorionic Gonadotropin, beta Subunit, Human _xblood |
| 650 | 0 | 4 |
_aDysgerminoma _xdrug therapy |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xtherapeutic use |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xblood |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aOvariectomy |
| 650 | 0 | 4 |
_aRespiration Disorders _xchemically induced |
| 650 | 0 | 4 |
_aalpha-Fetoproteins _xanalysis |
| 700 | 1 | _aCaliskan, Umran | |
| 700 | 1 | _aUcar, Canan | |
| 700 | 1 | _aYurtcu, Muslim | |
| 700 | 1 | _aArtac, Hasibe | |
| 700 | 1 | _aIlerisoy-Yakut, Zeynep | |
| 700 | 1 | _aReisli, Ismail | |
| 773 | 0 |
_tPediatric hematology and oncology _gvol. 24 _gno. 6 _gp. 431-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/08880010701451434 _zAvailable from publisher's website |
| 999 |
_c17241457 _d17241457 |
||